Cargando…
Breakthrough omicron COVID-19 infections in patients receiving the REGEN-Cov antibody combination
Autores principales: | Flahault, Adrien, Touchard, Justine, Péré, Hélène, Ulrich, Laetitia, Sabatier, Brigitte, Veyer, David, Lebeaux, David, Thervet, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837470/ https://www.ncbi.nlm.nih.gov/pubmed/35157894 http://dx.doi.org/10.1016/j.kint.2022.01.016 |
Ejemplares similares
-
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection
por: Planas, Delphine, et al.
Publicado: (2022) -
Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022) -
Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022) -
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023) -
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
por: Kaku, Chengzi I., et al.
Publicado: (2022)